Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Treatment Response With Faslodex® (500 mg) in Standard Clinical Practice Through a Retrospective Study

NCT01509625 is registered in ClinicalTrials.gov with Isabel Blancas as lead sponsor.

NCT NCT01509625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01509625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Treatment Response With Faslodex® (500 mg) in Standard Clinical Practice Through a Retrospective Study
Lead sponsor
Isabel Blancas
Phase
Observational
Overall status
Completed
Start date
January 31, 2012
Completion date
March 31, 2014
Enrollment
272 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasm of breast stage iv